Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Senseonics Holdings Inc SENS

Healthcare Medical Devices
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The... see more

Recent & Breaking News (NYSEAM:SENS)

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Health Care Service Corporation - Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas

Business Wire October 14, 2019

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire October 1, 2019

Senseonics Announces the Completion of US Patient Enrollment in the PROMISE 180-Day Sensor Clinical Study

Business Wire September 30, 2019

Senseonics Announces Two Positive Blue Cross Blue Shield Coverage Decisions for Eversense CGM

Business Wire September 3, 2019

Real-World Experience of Repeat Users Shows Long-Term Safety of the Implantable Eversense CGM System in the Home-Use Setting

Business Wire August 27, 2019

Senseonics Publishes Eversense® CGM Real-World Data from First U.S. Users

Business Wire August 21, 2019

Senseonics Holdings, Inc. Reports Second Quarter 2019 Financial Results

Business Wire August 7, 2019

Senseonics to Participate in the Canaccord Genuity Growth Conference

Business Wire July 25, 2019

Senseonics Holdings, Inc. Schedules Second Quarter 2019 Earnings Release and Conference Call for August 7, 2019 at 4:30 p.m. Eastern Time

Business Wire July 24, 2019

Senseonics Announces Pricing of $82.0 Million 5.25% Convertible Senior Notes Due 2025

Business Wire July 18, 2019

Senseonics Announces Pricing of Public Offering of Common Stock

Business Wire July 18, 2019

Senseonics Announces Commencement of Convertible Notes Offering

Business Wire July 16, 2019

Senseonics Announces Public Offering of Common Stock

Business Wire July 16, 2019

Senseonics Holdings, Inc. Reports Preliminary Second Quarter 2019 Net Revenue

Business Wire July 16, 2019

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire July 3, 2019

Senseonics Announces FDA Approval for a Non-Adjunctive Indication (Dosing Claim) for the Eversense® 90-day CGM System

Business Wire June 6, 2019

Senseonics to Present Real-World, Long-Term Safety Data of the First Implantable CGM Sensor at the American Diabetes Association's 79th Scientific Sessions

Business Wire June 5, 2019

Senseonics to Participate in the Raymond James Life Sciences and MedTech Conference

Business Wire June 4, 2019

Senseonics to Participate in the Guggenheim MedTech Disruptors Summit

Business Wire May 21, 2019

Senseonics Holdings, Inc. Reports First Quarter 2019 Financial Results

Business Wire May 9, 2019